-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Shvi9FQyq6nXr9WISrXZpAepvtxCMegcsWttucNuStrISdEipk9+J8n6/mVLbveZ swsTUZ+/S8trnxbGqv30+w== 0001209191-04-047416.txt : 20041005 0001209191-04-047416.hdr.sgml : 20041005 20041005144312 ACCESSION NUMBER: 0001209191-04-047416 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20041001 FILED AS OF DATE: 20041005 DATE AS OF CHANGE: 20041005 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: VAN NOSTRAND ROBERT L CENTRAL INDEX KEY: 0001225198 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15190 FILM NUMBER: 041065592 BUSINESS ADDRESS: STREET 1: OSI PHARMACEUTICALS INC STREET 2: 58 S. SERVICE RD. CITY: MELVILLE STATE: NY ZIP: 11747 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OSI PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000729922 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 133159796 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 58 SOUTH SERVICE RD. STREET 2: SUITE 110 CITY: MELVILLE STATE: NY ZIP: 11747 BUSINESS PHONE: 631-962-2000 MAIL ADDRESS: STREET 1: 58 SOUTH SERVICE RD. STREET 2: SUITE 110 CITY: MELVILLE STATE: NY ZIP: 11747 FORMER COMPANY: FORMER CONFORMED NAME: ONCOGENE SCIENCE INC DATE OF NAME CHANGE: 19920703 4 1 doc4.xml FORM 4 SUBMISSION X0202 4 2004-10-01 0 0000729922 OSI PHARMACEUTICALS INC OSIP 0001225198 VAN NOSTRAND ROBERT L C/O OSI PHARMACEUTICALS, INC. 58 SOUTH SERVICE ROAD, SUITE 110 MELVILLE NY 11747 0 1 0 0 VP, & Chief Financial Officer Common Stock 2004-10-01 4 M 0 2750 7.094 A 7516 D Common Stock 2004-10-01 4 S 0 49 60.75 D 7467 D Common Stock 2004-10-01 4 S 0 38 60.76 D 7429 D Common Stock 2004-10-01 4 S 0 25 60.77 D 7404 D Common Stock 2004-10-01 4 S 0 12 60.78 D 7392 D Common Stock 2004-10-01 4 S 0 62 60.80 D 7330 D Common Stock 2004-10-01 4 S 0 25 60.81 D 7305 D Common Stock 2004-10-01 4 S 0 12 60.83 D 7293 D Common Stock 2004-10-01 4 S 0 1231 60.96 D 6062 D Common Stock 2004-10-01 4 S 0 287 61.00 D 5775 D Common Stock 2004-10-01 4 S 0 37 61.05 D 5738 D Common Stock 2004-10-01 4 S 0 49 61.07 D 5698 D Common Stock 2004-10-01 4 S 0 37 61.09 D 5652 D Common Stock 2004-10-01 4 S 0 320 61.10 D 5332 D Common Stock 2004-10-01 4 S 0 12 61.11 D 5320 D Common Stock 2004-10-01 4 S 0 49 61.18 D 5271 D Common Stock 2004-10-01 4 S 0 12 61.19 D 5259 D Common Stock 2004-10-01 4 S 0 12 61.25 D 5247 D Common Stock 2004-10-01 4 S 0 49 61.30 D 5198 D Common Stock 2004-10-01 4 S 0 99 61.55 D 5099 D Common Stock 2004-10-01 4 S 0 197 61.60 D 4902 D Common Stock 2004-10-01 4 S 0 25 61.75 D 4877 D Common Stock 2004-10-01 4 S 0 111 61.83 D 4766 D Stock Option (Right to Buy) 7.094 2004-10-01 4 M 0 2750 0.00 D 1997-12-10 2006-12-09 Common Stock 2750 11155 D The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. One third of the stock option became exercisable one year after the date of the grant and the remainder vested ratably on a monthly basis over the succeeding 24 months. The stock option was granted pursuant to one of the Issuer's incentive and non-qualified stock option plans and is exempt under Rule 16b-3. Includes only options with the same termination date. Robert L. Van Nostrand 2004-10-05 -----END PRIVACY-ENHANCED MESSAGE-----